METTL3 along with C-MYC regulatory pathways have been verified in oral squamous cell carcinoma [33], lung cancer [34], bladder cancer [35], etc. EZH2 encodes a histone lysine N-methyltransferase. Here, EZH2 is linked to urinary bladder cancer.